Cell Therapy Latest Insights

RoslinCT and Lykan Bioscience Announce the Establishment of a Scientific Advisory Board

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

RoslinCT Appoints Alexandra Brownfield as Head of Business Development

RoslinCT Appoints Lee Warren as Chief Financial Officer

RoslinCT continues its growth plans by expanding its operations at Edinburgh Technopole

RoslinCT Announces the Appointment of Peter Coleman as CEO

RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture